Company Filing History:
3 out of 178 
2 out of 5,463 
Years Active: 2019-2023
Title: Yoko Irukayama: Innovator in Orexin Receptor Research
Introduction
Yoko Irukayama is a prominent inventor based in Tsukuba, Japan. She has made significant contributions to the field of pharmacology, particularly in the development of compounds that target orexin receptors. With a total of 3 patents to her name, her work is paving the way for new therapeutic options for various conditions.
Latest Patents
One of her latest patents is focused on a sulfonamide derivative or pharmaceutically acceptable acid-addition salt. This invention aims to provide a novel low-molecular-weight compound that exhibits orexin receptor agonist activity. It is expected to be useful as a prophylactic or therapeutic agent for narcolepsy and similar conditions. The compound is represented by a specific formula, which is detailed in the patent description.
Another significant patent by Irukayama is related to a morphinan derivative and its medical usage. The purpose of this invention is to offer a compound that serves as a prophylactic or therapeutic agent for various diseases and symptoms associated with orexin receptors. The morphinan derivative demonstrates excellent selectivity and antagonism against orexin receptors, providing promising therapeutic effects on drug dependence.
Career Highlights
Yoko Irukayama has worked at esteemed institutions such as the University of Tsukuba and the University of Texas System. Her research has focused on the pharmacological implications of orexin receptors, contributing to advancements in the field.
Collaborations
Throughout her career, Irukayama has collaborated with notable colleagues, including Hiroshi Nagase and Masashi Yanagisawa. These partnerships have enhanced her research and broadened the impact of her inventions.
Conclusion
Yoko Irukayama's innovative work in the field of orexin receptor research is making significant strides in pharmacology. Her patents reflect her commitment to developing new therapeutic agents that could improve the quality of life for individuals suffering from various conditions.